Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...

By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.

An international team of scientists have discovered that soap could be important to helping our understanding of complex ...

An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...

Lines of tractors have taken to roads across Northern Ireland to protest against proposed changes to inheritance tax rules.

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

Eagan’s Minnesota Ice Festival is now home to the world's largest ice maze, according to the Guinness World Records ...